Zavesca
How to Report an Adverse Reaction to a Medication »
"Potential drug treatments are tested on paper, in laboratories and eventually in thousands of people. But every drug that goes through this cycle – every drug that FDA approves – carries some risk. One of the first lines of defense against "...
Read the How to Report an Adverse Reaction to a Medication article »
Zavesca
ZAVESCA®
(miglustat) Capsules, l00mg
DRUG DESCRIPTION
ZAVESCA® (miglustat capsules, 100mg) is an inhibitor of the enzyme glucosylceramide synthase, which is a glucosyl transferase enzyme responsible for the first step in the synthesis of most glycosphingolipids. ZAVESCA® (miglustat) is an N-alkylated imino sugar, a synthetic analog of D-glucose.
The chemical name for miglustat is l,5-(butylimino)-l,5-dideoxy-D-glucitol with the chemical formula C10H21NO4 and a molecular weight of 219.28.
![ZAVESCA®
[miglustat] Structural Formula Illustration](http://images.rxlist.com/images/rxlist/zavesca1.gif) |
Miglustat is a white to off-white crystalline solid and has a bitter taste. It is highly soluble in water ( > 1000mg/mL as a free base).
ZAVESCA® (miglustat) is supplied in hard gelatin capsules each containing 100 mg miglustat for oral administration. Each ZAVESCA® (miglustat) 100 mg capsule also contains sodium starch glycollate, povidone (K30), and magnesium stearate. Ingredients in the capsule shell include gelatin and titanium dioxide, and the shells are printed with edible ink consisting of black iron oxide and shellac.
Last reviewed on RxList: 1/11/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Zavesca Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
